Patent details

EP2558063 Title: VERY LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT

Basic Information

Publication number:
EP2558063
PCT Application Number:
EP2011055716
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117149674
PCT Publication Number:
WO2011128336
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
VERY LOW-DOSED SOLID ORAL DOSAGE FORMS FOR HRT
French Title of Invention:
FORMULATION SOLIDE À TRÈS BAS DOSAGE POUR LA THÉRAPIE HORMONALE DE REMPLACEMENT (MÉNOPAUSE)
German Title of Invention:
SEHR NIEDRIGDOSIERTE FESTE DARREICHUNGSFORMEN FÜR HRT
SPC Number:

Dates

Filing date:
12/04/2011
Grant date:
29/09/2021
EP Publication Date:
20/02/2013
PCT Publication Date:
20/10/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/09/2021
EP B1 Publication Date:
29/09/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/04/2022
Expiration date:
12/04/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/09/2021
 
 

Name:
Bayer Intellectual Property GmbH
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Inventor

1

Name:
MLETZKO, Stephan
Address:
Germany (DE)

2

Name:
SCHÜRMANN, Rolf
Address:
Germany (DE)

3

Name:
GUDE, Kerstin
Address:
Germany (DE)

Priority

Priority Number:
10160072
Priority Date:
15/04/2010
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 31/585; A61K 31/565; A61K 31/57; A61K 31/566; A61P 5/24; A61P 5/30; A61P 9/00; A61P 15/00; A61P 15/12; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202139
Publication date:
29/09/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages